GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Reckitt Benckiser Group RKT.L · GBp

Consumer Staples · Household Products · LSE · 🇬🇧 United Kingdom

FTSE 100

Compare

5,578.00p

-0.21%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

About Reckitt Benckiser Group

Its shares trade on LSE under the ticker RKT.L. It has been listed since 23 October 2007. It is a member of the FTSE 100. In the fiscal year to 31 December 2025, it reported revenue of £14.21bn and net income of £3.18bn. At that date it held total assets of £25.07bn and shareholders' equity of £7.75bn.

Reckitt Benckiser Group Plc engages in the manufacture and trade of health, hygiene and home products. The company is headquartered in Slough, Berkshire. The company went IPO on 2007-10-23. The firm's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The firm's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Queen V, Vanish and Woolite.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Household Products
Listed since
23 Oct 2007
Employees
43,500
Website
rb.com ↗

Leadership

Pay as last reported

  • Sir D. Jeremy DarrochNon-Executive Independent Chairman of the Board£508,333
  • Mr. Kris LichtChief Executive Officer, Executive Director, since 2019£5.8m
  • Ms. Shannon EisenhardtChief Financial Officer, Executive Director, since 2023£3.0m
  • Mr. Eric GilliotPresident, Europe
  • Mr. Nitish KapoorPresident - Emerging Markets
  • Mr. Jerome LemairePresident, North America
  • Ms. Susan SholtisPresident - Nutrition
  • Mr. Ranjay RadhakrishnanChief Human Resources Officer
  • Ms. Catheryn O'RourkeGeneral Counsel, Company Secretary
  • Mr. Ryan DulleaChief Category Growth Officer
  • Mr. Harald EmbergerChief Supply Officer
  • Ms. Angela NaefChief Research and Development Officer

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
84
Environment
83
Social
88
Governance
81
Direct emissions (scope 1)
107,029 t
Energy emissions (scope 2)
232,882 t
Value chain emissions (scope 3)
36,612,123 t
Women in the workforce
45%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Reckitt Benckiser employs 43,500 full-time employees globally.
  • The ENA segment covers Europe, North America, Australia, and New Zealand.
  • DvM segment includes Africa, South Asia, and Latin America.

Weaknesses

  • Reckitt Benckiser's DvM segment excludes Israel from Middle East operations.
  • The company's hygiene products include pest control and acne treatments.
  • The firm's portfolio brands like Durex and Mucinex are well-known globally.

Opportunities

  • Reckitt Benckiser can expand its home products in the ASEAN region.
  • The company can leverage its ENA segment for new market entries.
  • DvM segment offers growth potential in Africa and South Asia.

Threats

  • Reckitt Benckiser faces competition in the Health Care sector.
  • The company's DvM segment excludes Israel, limiting market access.
  • The firm's hygiene products face regulatory challenges in Europe.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.